がん対策推進総合研究事業
（○：委員長）
| 足立 壯一 | 京都大学医学部人間健康科学系専攻 教授 | ||
| 血液腫瘍学 | |||
| Taga T, Moriya-Saito A, Kudo K, Tomizawa D, Terui K, Moritake H, Kinoshita A, Iwamoto S, Nakayama H, Takahashi H, Tawa A, Shimada A, Taki T, Kigasawa H, Koh K, Adachi S. Clinical characteristics and outcome of refractory/relapsed myeloid leukemia in children with Down syndrome. Blood. 2012 Aug 30;120(9):1810-5. doi: 10.1182/blood-2012-03-414755. Epub 2012 Jul 9 | |||
| Kinoshita A, Miyachi H, Matsushita H, Yabe M, Taki T, Watanabe T, Saito AM, Tomizawa D, Taga T, Takahashi H, Matsuo H, Kodama K, Ohki K, Hayashi Y, Tawa A, Horibe K and Adachi S. Acute myeloid leukemia with myelodysplastic features in children. A report of Japanese Pediatric Leukemia/Lymphoma Study Group. Brit J Haematol 2014 Oct;167(1):80-6. doi: 10.1111/bjh.12993. | |||
| Takahashi H, Watanabe T, Kinoshita A, Yuza Y, Moritake H, Terui K, Iwamoto S, Nakayama H, Shimada A, Kudo K, Taki T, Yabe M, Matsushita H, Yamashita Y, Koike K, Ogawa A, Kosaka Y, Tomizawa D, Taga T, Saito AM, Horibe K, Nakahata T, Miyachi H, Tawa A, and Adachi S. High event-free survival rate with minimum-dose-anthracycline treatment in childhood acute promyelocytic leukaemia: A nationwide prospective study by the Japanese Paediatric Leukaemia/Lymphoma Study Group. Br J Haematol. 2016 Aug;174(3):437-43. doi: 10.1111/bjh.14068. Epub 2016 Mar 31 | |||
| 片渕 秀隆 | 熊本大学・名誉教授 くまもと森都総合病院・特別顧問 |
||
| 産科婦人科学 | |||
| Nogami Y, Makabe T, Komatsu H, Kawana K, Okamoto A, Mikami M, Katabuchi H, The COVID-19 Task Force of the Japan Society of Gynecologic Oncology. Impact of COVID-19 on cervical cancer screening in Japan: A survey of population-based screening in urban Japan by the Japan Society of Gynecologic Oncology. J Obstet Gynaecol Res. 2021 DOI: 10.1111/jog.15130. | |||
| Nogami Y, Kawatsu K, Makabe T, Hasegawa Y, Yokoyama Y, Kawana K, Okamoto A, Mikami M, Katabuchi H, The COVID-19 Task Force of the Japan Society of Gynecologic Oncology. Impact of COVID-19 on gynecologic cancer treatment in Japan: A nationwide survey by the Japan Society of Gynecologic Oncology (JSGO). J Gynecol Oncol. 2022 DOI: 10.3802/jgo.2022.33.e8. | |||
| Nagase S, Ohta T, Takahashi F, Yaegashi N, Enomoto T, Katabuchi H, Kawana K, Kobayashi H, Kobayashi Y, Shozu M, Baba T, Morishige K, Yoshida Y, Yoshino K, Yamagami W, Tokunaga H. Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual patient report for 2018 and annual treatment report for 2013 J Obstet Gynaecol Res. 2022 DOI: 10.1111/jog.15134. | |||
| 岸田徹 | NPO法人がんノート 代表理事 | ||
| がん患者支援/政策 | |||
| 岸田徹・AYA世代のがんが恋愛や結婚に及ぼす影響・がんサバイバーシップ研究（がん研究振興財団）・平成28年度 | |||
| 岸田徹・AYA世代のがん患者のピアサポート―「がんノート」の役割と展望―保健の科学（杏林書院）・ 61巻・2019年08月 | |||
| 白井 千香 | 枚方市保健所 所長 | ||
| 公衆衛生 | |||
| ＜解説＞ 新型コロナウイルス感染症に対する地方自治体および保健所の対応 ―流行状況の推移およびウイルス変異に応じた感染症対応の模索― 白井千香,内田勝彦,清古愛弓,藤田利枝他, 保健医療科学(保健医療科学院）,Vol.71,No.4,292-304 ,2022 |
|||
| ＜特別報告＞ 新型コロナウイルス感染症対応の経験から得た、地域における自分事のしくみづくり.白井千香, 社会医学研究（日本社会医学会）,Vol.40,No.1,60-63,2023 |
|||
| ＜特集・寄稿＞ わが国のHIV/AIDS対策の目標 全ての医療機関や住民がHIV/AIDSや性感染症に関わるために．白井千香. 公衆衛生（医学書院）,Vol.84,No.12,807-811,2020 |
|||
| 杉山雄大 | 国立国際医療研究センター研究所糖尿病情報センター 医療政策研究室長／筑波大学医学医療系ヘルスサービスリサーチ分野 教授 | ||
| ヘルスサービスリサーチ | |||
| Suto M, Sugiyama T, Imai K, Furuno T, Hosozawa M, Ichinose Y, Ihana-Sugiyama N, Kodama T, Koizumi R, Shimizu-Motohashi Y, Murata S, Nakamura Y, Niino M, Sato M, Taguchi R, Takegami M, Tanaka M, Tsutsumimoto K, Usuda K, Takehara K, Iso H. Studies of Health Insurance Claims Data in Japan: A Scoping Review. JMA J. 2023;6:233-245. | |||
| Watanabe T, Sugiyama T, Imai K, Higashi T. How are new drugs disseminated in Japan? Analysis using the National Database of Health Insurance Claims of Japan. Cancer Sci. 2022; 113: 1771-1778. | |||
| Sugiyama T, Imai K, Ihana-Sugiyama N, Tanaka H, Yanagisawa-Sugita A, Sasako T, Higashi T, Okamura T, Yamauchi T, Ueki K, Ohsugi M, Kadowaki T. Variation in process quality measures of diabetes care by region and institution in Japan during 2015-2016: An observational study of nationwide claims data. Diabetes Res Clin Pract. 2019; 155: 107750. | |||
| 〇 | 土岐祐一郎 | 大阪大学大学院医学系研究科 消化器外科学 教授 | |
| 消化器外科 | |||
| Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma. Doki Y, Ajani JA, Kato K, Xu J, Wyrwicz L, Motoyama S, Ogata T, Kawakami H, Hsu CH, Adenis A, El Hajbi F, Di Bartolomeo M, Braghiroli MI, Holtved E, Ostoich SA, Kim HR, Ueno M, Mansoor W, Yang WC, Liu T, Bridgewater J, Makino T, Xynos I, Liu X, Lei M, Kondo K, Patel A, Gricar J, Chau I, Kitagawa Y; CheckMate 648 Trial Investigators. N Engl J Med. 2022 Feb 3;386(5):449-462. |
|||
| Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Adachi S, Takiguchi S, Okada K, Yamamoto K, Yamasaki M, Miyata H, Nakajima K, Fujiwara Y, Hosoda H, Kangawa K, Mori M, Doki Y. Gastroenterology. 2010 Apr;138(4):1312-20. |
|||
| Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003). Yamasaki M, Yasuda T, Yano M, Hirao M, Kobayashi K, Fujitani K, Tamura S, Kimura Y, Miyata H, Motoori M, Shiraishi O, Makino T, Satoh T, Mori M, Doki Y. Ann Oncol. 2017 Jan 1;28(1):116-120. |
|||
| 西田 博 | 医療法人城見会アムスニューオータニクリニック内視鏡センター センター長 | ||
| 消化器病学 | |||
| Helicobacter pylori eradication treatment for gastric carcinoma prevention in asymptomatic or dyspeptic adults: systematic review and Bayesian meta-analysis of randomized controlled trials Teruhiko Terasawa, Chisato Hamashima, katsuaki Kato, Isao Miyashiro, Takaki Yoshikawa, Reo Tataku, Hiroshi Nishida BMJ Open 2019; 9: 9 http://dx.doi.org/10.1136/bmjopen-2018-026002 |
|||
| 便潜血検査を用いた大腸がんスクリーニング‒大腸癌の生物学的特性を考慮したstrategy－ 西田 博 大腸がんperspective 4 (3): 203-208, 2019 |
|||
| Assessment of Cancer Screenings and Impact of Computer Simulation Hiroshi Nishida, Akiko Harada, Takahiro Matsumoto, Tomoko Tani, Yoshihide Tatsumi, Etsuko Nagai and Shuko Mayumi International Journal of Gastroenterology Disorders & Therapy 2015; 2:119 http://dx.doi.org/10.15344/2393-8498/2015/119 |
|||
| 馬場秀夫 | 熊本大学大学院生命科学研究部消化器外科学･教授 | ||
| 消化器外科学 | |||
| Akiyama T, Yasuda T, Uchihara T, Yasuda-Yoshihara N, Tan BJY, Yonemura A, Semba T, Yamasaki J, Komohara Y, Ohnishi K, Wei F, Fu L, Zhang J, Kitamura F, Yamashita K, Eto K, Iwagami S, Tsukamoto H, Umemoto T, Masuda M, Nagano O, Satou Y, Saya H, Tan P, Baba H, Ishimoto T: Stromal Reprogramming through Dual PDGFRalpha/beta Blockade Boosts the Efficacy of Anti-PD-1 Immunotherapy in Fibrotic Tumors. Cancer Res 83:753-770, 2023 | |||
| Imai K, Baba H: Initially unresectable colorectal liver metastases: the best therapeutic regimens. Lancet Oncol. 24(7):711-713, 2023 | |||
| Ishimoto T, Miyake K, Nandi T, Yashiro M, Onishi N, Huang KK, Lin SJ, Kalpana R, Tay ST, Suzuki Y, Cho BC, Kuroda D, Arima K, Izumi D, Iwatsuki M, Baba Y, Oki E, Watanabe M, Saya H, Hirakawa K, Baba H, Tan P: Activation of transforming growth factor beta 1 signaling in gastric cancer-associated fibroblasts increases their motility, via expression of rhomboid 5 homolog 2, and ability to induce invasiveness of gastric cancer cells. Gastroenterology 153:191-204 e116, 2017 | |||
| 堀田知光 | 国立病院機構名古屋医療センター 名誉院長 | ||
| 血液内科 | |||
| Ogura M, Yamamoto K, Morishima Y, Wakabayashi M, Tobinai K, Ando K, Hotta T, et al. Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406. Cancer Sci 2023 Aug;114(8):3461-3465. | |||
| Kinoshita T, Watanabe T, Itoh K, Yoshimura K, Tobinai K, Ogura M, Hotta T, et al. Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study - JCOG0108A. J Clin Exp Hematop. 2021;61(1):35-41. | |||
| Watanabe T, Tobinai K, Wakabayashi M, Morishima Y, Hotta T, et al. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial. The Lancet Haematol. 2018;5(11):e520-e31. | |||
